Senior Investigator Profile

TitleProfessor
First NameAndrew
SurnameWardlaw
Award StatusTerm 2
Current PostProfessor of Allergy and Respiratory Medicine
DepartmentInstitute for Lung Health, Department of Respiratory medicine, allergy and thoracic surgery
Telephone44 116 2563841
Emailaw24@le.ac.uk
InstitutionUniversity Hospitals Of Leicester NHS Trust
NHS TrustUniversity Hospitals Of Leicester NHS Trust
Region NameEast Midlands
Primary Research FieldRespiratory Diseases
Secondary Research FieldImmunology - Allergy
BiographyProfessor Wardlaw undertook his medical degree in Cambridge and London and his initial clinical training in London. He then did a PhD (1984-1987) on the pathogenesis of asthma under the supervision of Professor Barry Kay at the National Heart and Lung Institute. He did a post-doctoral fellowship for two years at Harvard with Professor Tim Springer on the molecular biology of leukocyte adhesion deficiency (1987-1989), before returning to the Brompton Hospital to complete his clinical training in allergy and respiratory medicine (1989-1992). He then took up a post as the first respiratory academic in the University of Leicester in 1992. In 1999 he was appointed to the inaugural chair in respiratory medicine in Leicester and in 2000 he became the Director of the Leicester Institute for Lung Health. The adult respiratory group in Leicester now consists of five clinical professors of respiratory medicine, four clinical senior lecturers, and a non-clinical reader in respiratory immunology. Together they supervise a research team team of ~100 staff. The group was awarded a NIHR respiratory BRU in 2012 with Professor Wardlaw as director. Professor Wardlaw was the President of the British Society for Allergy and Clinical Immunology (2002-2006) and chair of the RCP-RCPath joint committee on immunology and allergy between 2008 and 2012 where he has led the development of an allergy accreditation process. He has been the editor in chief of Clinical Experimental Allergy since 2008 and is currently a member of the executive of the International Eosinophil Society where he is responsble for organsing the biennial scientific meeting in Oxford in 2013. His research has been focussed on the relationship between the clinical features of asthma and its immunopathology, in particular the role of the eosinophil in asthma. Most recently he has become interested in the role of fungal allergy in causing eosinophilic airway disease including asthma. He has a weekly difficult asthma clinic and runs a specialist clinic for people with hypereosinophilic disease. He is an author on ~200 research papers cited on PubMed which together have been cited over 15,500 times and he had a ‘h’ index of ~60.
 

 CVName
View CV 
















<< Search SI Directory